Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP015K PK in Hepatic Impairment
NCT02586194Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Primary endpoint: Area Under the Concentration-Time Curve from Time Zero to Infinity at 72 hours. Started Dec 2015; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02586194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586194.